ECOR Research and Charts

ECOR - electroCore Inc (Healthcare: Medical Instruments & Supplies)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-04-04)

Last 5.66	Change ⇓ -0.21 (-3.58%)	Volume 126,861
	Open 5.65	High 5.86	Low 5.24

8EMA (Daily) 6.50	40EMA (Daily) 10.66	50EMA (Daily) 11.27	STO (Daily) 6.935	MACD Hist (Daily) -0.048
8EMA (Weekly) 10.119	40EMA (Weekly) 11.01	50EMA (Weekly) 10.45	STO (Weekly) 9.033	MACD Hist (Weekly) -2.984


Company Profile
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.